I Missed My Retatrutide Injection

    By Trimi Medical Team11 min read

    Missing a weekly retatrutide injection happens, and it is usually straightforward to manage. Like other weekly GLP-1 medications, the key factor is how many days have passed since your scheduled injection. The general approach follows the same guidelines established for semaglutide and tirzepatide, adapted for retatrutide's specific pharmacokinetics (Jastreboff et al., NEJM 2023).

    Medical Disclaimer: This article is for informational purposes only. Retatrutide is an investigational drug not yet approved by the FDA. Contact your healthcare provider for personalized guidance on missed doses.

    What to Do Based on Days Missed

    Days LateActionResume Schedule
    1-3 days lateTake missed dose as soon as possibleResume regular schedule next week
    4-6 days lateTake missed dose; adjust next dose timingWait at least 3 days before next dose
    7+ days (full week missed)Skip the missed dose entirelyTake next dose on regular schedule day
    2+ weeks missedContact provider; may need to re-titrateProvider will advise starting dose

    What Happens When You Miss a Dose

    As retatrutide's effects wear off after a missed dose, you may notice several changes within 2-5 days:

    • Appetite returns: The appetite-suppressing effects diminish, and hunger may return to pre-treatment levels or even rebound slightly
    • Food noise increases: Thoughts about food may become more frequent and intrusive
    • Gastric emptying normalizes: Food may move through the stomach faster, leading to less prolonged fullness after meals
    • Blood sugar effects decrease: Patients with diabetes may see fasting glucose creep upward
    • Potential GI effects on restart: Resuming after a gap may trigger mild nausea similar to when you first started

    Missing More Than Two Weeks

    If you have missed two or more consecutive weeks, contact your provider before resuming. After an extended break, your body may have partially de-adapted to the medication, and resuming at your previous dose could cause more severe side effects. Your provider may recommend restarting at a lower dose and re-titrating, though often more quickly than the initial titration schedule.

    Will One Missed Dose Cause Weight Regain?

    A single missed dose will not cause meaningful weight regain. Any temporary weight increase is likely from water retention or increased food intake during the brief period of reduced appetite suppression. The medication's effects overlap between doses, so one missed dose does not create a complete gap in coverage.

    Preventing Missed Doses

    • Set a recurring weekly alarm on your phone
    • Associate injection day with a consistent weekly event
    • Keep medication visible in the refrigerator (but properly stored)
    • Use a medication tracking app
    • Tell a partner or family member your injection day so they can remind you
    • If traveling, plan ahead: bring medication with a cold pack and set extra reminders

    Changing Your Injection Day

    If your current injection day is inconvenient and contributing to missed doses, you can change it. To shift your injection day, take your next dose on the new preferred day (ensuring at least 3 days have passed since the last injection). Then continue weekly from that new day. You do not need to re-titrate to change injection days.

    GLP-1 Treatment With Consistent Support

    Trimi offers compounded semaglutide ($99/month) and compounded tirzepatide ($125/month) with reliable medication delivery and medical support for dosing questions. Learn how Trimi works.

    Frequently Asked Questions

    Should I double my next dose if I missed one?

    Absolutely not. Never take a double dose to make up for a missed injection. Take your regular dose as soon as you remember (if within the week) or skip and resume on schedule.

    Will I feel sick when I restart after missing a dose?

    You may experience mild GI symptoms similar to when you first started, particularly if you missed more than one week. These are typically milder and shorter-lived than initial startup effects.

    How many doses can I miss before I need to re-titrate?

    Generally, missing 2 or more consecutive weeks warrants discussion with your provider about re-titration. A single missed week usually does not require restarting at a lower dose.

    Can I take my dose a day early?

    Taking your dose 1-2 days early is generally acceptable and preferable to missing the dose entirely (for example, if you will be traveling on your usual injection day). Ensure at least 5 days between injections.

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    Related Reading

    Can I double the dose of retatrutide?

    No — retatrutide is investigational and not FDA-approved as of May 2026. Double-dosing or off-protocol dosing is unsupported by clinical evidence and is unsafe. Phase 2 TRIUMPH-1 dosed retatrutide up to 12 mg/week; phase 3 trial doses are higher (per ClinicalTrials.gov listings) but not yet reported in peer-reviewed literature. Double-dosing investigational medications outside clinical trial protocols carries unknown pharmacokinetic, safety, and efficacy risks — the full dose-response curve isn't yet characterized. Patients should not seek 'research peptide' retatrutide outside legitimate clinical trial enrollment; sellers operating outside trials provide no quality control over dose accuracy or sterility. For patients seeking weight-loss treatment now, FDA-approved tirzepatide (Zepbound, Mounjaro) at standard doses (2.5-15 mg/week) is the closest comparable option, with well-characterized dose-response data from SURMOUNT and SURPASS trials.

    Investigational; double-dosing unsafe + unsupported.
    Phase 2 max: 12 mg/week.
    Today's accessible alternative: tirzepatide at standard 2.5-15 mg/week.

    Key Takeaways

    • Retatrutide is investigational and not FDA-approved as of May 2026; double-dosing or off-protocol dosing is unsupported and unsafe.
    • Phase 2 TRIUMPH-1 dosed up to 12 mg/week; phase 3 trial doses are higher (per ClinicalTrials.gov listings) but not yet reported in peer-reviewed literature.
    • Double-dosing investigational medications outside clinical trial protocols carries unknown pharmacokinetic, safety, and efficacy risks — the dose-response curve isn't fully characterized.
    • Patients should not seek 'research peptide' retatrutide outside legitimate clinical trial enrollment; sellers operating outside trials provide no quality control over dose accuracy or sterility.
    • For patients seeking treatment now, FDA-approved tirzepatide (Zepbound, Mounjaro) at standard doses (2.5-15 mg/week) is the closest comparable option.
    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Dr. Asad Niazi, MD, MPH

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    It's only been 2 weeks since I've been taking the VialsRx meds from Trimi. The medication showed up pretty quickly (about 4 days after getting approval from Trimi prescriber) and I received 3 vials for my first 3 months on the subscription. For the price and convenience my take is that Trimi and VialsRx is good.

    Outcome: 4-day delivery; 3 vials for first 3 months; price + convenience verdict positive

    Really great customer service! Fast shipment.

    Outcome: Fast shipment

    Amy KeithFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Eli Lilly and Company (2025). Zepbound (tirzepatide) prescribing information. U.S. Food and Drug Administration.Read Study
    2. Jastreboff AM, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. The New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2206038

    Was this article helpful?

    Keep Reading

    Get answers to the 30 most common questions about retatrutide, from how it works and side effects to cost, availability, eligibility, and results based on Phase 2 clinical trial data.

    Retatrutide

    Retatrutide 2mg

    Retatrutide 4mg is the first therapeutic dose — where real weight loss begins. 17.5% average weight loss at this dose alone. Expected results, side effects, and when to consider escalating.

    Step-by-step retatrutide injection: 6-day half-life, once-weekly dosing, site rotation, and how to time shots for fewer side effects and better weight loss results.

    Accidentally took a double dose of retatrutide? Learn what to expect, which symptoms to watch for, when to seek medical attention, and how to prevent future dosing errors.

    Start your GLP-1 journey — from $99/mo

    Get Started